Market News
Monday, November 21, 2016
BRIEF-Aeglea Bio Therapeutics announces results of preclinical studies of AEB3103
* Announced results of preclinical studies of AEB3103
showing suppressed growth of tumors in models of prostate,
breast cancer
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment